These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 18348865

  • 1. Redox-mediated modification of PLZF by SUMO-1 and ubiquitin.
    Kang SI, Choi HW, Kim IY.
    Biochem Biophys Res Commun; 2008 May 16; 369(4):1209-14. PubMed ID: 18348865
    [Abstract] [Full Text] [Related]

  • 2. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
    Kang SI, Chang WJ, Cho SG, Kim IY.
    J Biol Chem; 2003 Dec 19; 278(51):51479-83. PubMed ID: 14527952
    [Abstract] [Full Text] [Related]

  • 3. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes.
    Bossis G, Melchior F.
    Mol Cell; 2006 Feb 03; 21(3):349-57. PubMed ID: 16455490
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-32α modulates promyelocytic leukemia zinc finger gene activity by inhibiting protein kinase Cɛ-dependent sumoylation.
    Park YS, Kang JW, Lee DH, Kim MS, Bak Y, Yang Y, Lee HG, Hong J, Yoon DY.
    Int J Biochem Cell Biol; 2014 Oct 03; 55():136-43. PubMed ID: 25178676
    [Abstract] [Full Text] [Related]

  • 5. SUMO modification modulates the transrepression activity of PLZF.
    Chao TT, Chang CC, Shih HM.
    Biochem Biophys Res Commun; 2007 Jun 29; 358(2):475-82. PubMed ID: 17498654
    [Abstract] [Full Text] [Related]

  • 6. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
    Antoine K, Prosperi MT, Ferbus D, Boule C, Goubin G.
    Mol Cell Biochem; 2005 Mar 29; 271(1-2):215-23. PubMed ID: 15881673
    [Abstract] [Full Text] [Related]

  • 7. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
    Ling Y, Sankpal UT, Robertson AK, McNally JG, Karpova T, Robertson KD.
    Nucleic Acids Res; 2004 Mar 29; 32(2):598-610. PubMed ID: 14752048
    [Abstract] [Full Text] [Related]

  • 8. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J, Goodson ML, Hong Y, Sarge KD.
    J Biol Chem; 2008 Mar 21; 283(12):7464-9. PubMed ID: 18211895
    [Abstract] [Full Text] [Related]

  • 9. The promyelocytic leukemia zinc finger protein down-regulates apoptosis and expression of the proapoptotic BID protein in lymphocytes.
    Parrado A, Robledo M, Moya-Quiles MR, Marín LA, Chomienne C, Padua RA, Alvarez-López MR.
    Proc Natl Acad Sci U S A; 2004 Feb 17; 101(7):1898-903. PubMed ID: 14769944
    [Abstract] [Full Text] [Related]

  • 10. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL, Hsiao HH, Yeh YY, Shia HL, Chen YL, Liang PH, Wang AH, Khoo KH, Shoei-Lung Li S.
    J Biol Chem; 2004 Sep 17; 279(38):39653-62. PubMed ID: 15272016
    [Abstract] [Full Text] [Related]

  • 11. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
    Wu R, Fang J, Liu M, A J, Liu J, Chen W, Li J, Ma G, Zhang Z, Zhang B, Fu L, Dong JT.
    J Biol Chem; 2020 May 08; 295(19):6741-6753. PubMed ID: 32249212
    [Abstract] [Full Text] [Related]

  • 12. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
    Kim EJ, Park JS, Um SJ.
    Biochem Biophys Res Commun; 2008 Dec 19; 377(3):952-6. PubMed ID: 18955028
    [Abstract] [Full Text] [Related]

  • 13. The promyelocytic leukemia zinc finger (PLZF) protein exerts neuroprotective effects in neuronal cells and is dysregulated in experimental stroke.
    Seidel K, Kirsch S, Lucht K, Zaade D, Reinemund J, Schmitz J, Klare S, Li Y, Schefe JH, Schmerbach K, Goldin-Lang P, Zollmann FS, Thöne-Reineke C, Unger T, Funke-Kaiser H.
    Brain Pathol; 2011 Jan 19; 21(1):31-43. PubMed ID: 20731660
    [Abstract] [Full Text] [Related]

  • 14. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML, Kennett SB, Moorefield KS, Simmons SO, Brattain MG, Horowitz JM.
    Cell Signal; 2005 Feb 19; 17(2):153-66. PubMed ID: 15494207
    [Abstract] [Full Text] [Related]

  • 15. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
    Tatemichi Y, Shibazaki M, Yasuhira S, Kasai S, Tada H, Oikawa H, Suzuki Y, Takikawa Y, Masuda T, Maesawa C.
    Cancer Sci; 2015 Jul 19; 106(7):848-56. PubMed ID: 25891951
    [Abstract] [Full Text] [Related]

  • 16. SUMO modification of NZFP mediates transcriptional repression through TBP binding.
    Kim M, Chen Z, Shim MS, Lee MS, Kim JE, Kwon YE, Yoo TJ, Kim JY, Bang JY, Carlson BA, Seol JH, Hatfield DL, Lee BJ.
    Mol Cells; 2013 Jan 19; 35(1):70-8. PubMed ID: 23269432
    [Abstract] [Full Text] [Related]

  • 17. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
    Truong K, Lee TD, Chen Y.
    J Biol Chem; 2012 May 04; 287(19):15154-63. PubMed ID: 22403398
    [Abstract] [Full Text] [Related]

  • 18. The Promyelocytic Leukemia Zinc Finger (PLZF ) gene is a novel transcriptional target of the CCAAT-Displacement-protein (CUX1) repressor.
    Fréchette I, Darsigny M, Brochu-Gaudreau K, Jones C, Boudreau F.
    FEBS J; 2010 Oct 04; 277(20):4241-53. PubMed ID: 20945532
    [Abstract] [Full Text] [Related]

  • 19. SUMO modification is required for in vivo Hox gene regulation by the Caenorhabditis elegans Polycomb group protein SOP-2.
    Zhang H, Smolen GA, Palmer R, Christoforou A, van den Heuvel S, Haber DA.
    Nat Genet; 2004 May 04; 36(5):507-11. PubMed ID: 15107848
    [Abstract] [Full Text] [Related]

  • 20. Control of SUMO and Ubiquitin by ROS: Signaling and disease implications.
    Stankovic-Valentin N, Melchior F.
    Mol Aspects Med; 2018 Oct 04; 63():3-17. PubMed ID: 30059710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.